Skip to content

Demonstration report · Bioinformatics · Dermo-cosmetics

What a GENXMAP RNA-seq report looks like: a dermo-cosmetic example

A worked example of the report we deliver for a bulk RNA-seq study on ex vivo skin explants, comparing untreated explants with explants exposed to a dermo-cosmetic active. It shows the structure, the figures and the level of documentation. It is not the result of a real study.

Demonstration data. All data on this page are for demonstration only. No real product, client or study is described.

Model: ex vivo skin explant Technique: bulk RNA-seq Data: synthetic, for demonstration Genome: GRCh38.p14 / GENCODE v43 Author: Raheleh Shayan, PhD Updated: October 2026

In the portal

The same report, interactive in your portal

Click a gene, open a pathway: in the client portal, the transcriptomics report is interactive, and the selected data export as CSV. Partners on a joint project find the same results in the partner portal, with shared documents, milestones and discussions.

  • Client portalProjects, results and orders
  • Partner portalJoint projects, documents and milestones
Demonstration data

Hover over a point to read the gene.

01Quality control

Before any biological comparison, every library is screened on alignment rate, base quality, GC content and duplication, split by condition, to rule out a technical explanation for any downstream signal.

Per base sequence qualityMean Phred quality score by read position, per FASTQ file150100150152025303540Position in read (bp)Mean quality score (Phred)ConditionActive-treatedUntreated
Figure 1. Per-base sequence quality. Mean Phred quality score at each position along the reads, one line per sequencing file, colored by condition. The green band marks good quality (above 28), orange acceptable, red poor. All files stay in the green band along the whole read, with no condition lagging behind: base quality cannot explain a later difference between groups.
Per sequence GC contentGC content distribution across reads, per FASTQ file02550751000123% GC% of readsConditionActive-treatedUntreated
Figure 2. GC content distribution. Share of reads (y-axis) at each GC percentage (x-axis), one line per sequencing file. The files share a single, smooth peak and overlap across conditions. A second peak or a shifted curve would point to contamination or a library problem; neither is seen here.

02Analysis pipeline

A reproducible pipeline from alignment to functional interpretation, every tool and parameter version-controlled and documented for audit and reuse.

STAR 2.7.10a, two-passSalmon 1.10.0DESeq2 1.40.2 (VST) clusterProfiler 4.8.1GO and KEGG ORAGSEA, MSigDB Hallmark

03Principal component analysis

In this simulated example, PCA on VST-normalized counts places the treatment condition as the main source of variance, with the two groups separated before any statistical test is run. On real data, this is where a batch or donor effect would show up first.

Principal component analysisMain separation driven by exposure to the dermo-cosmetic activeC1 · PC1 -1.7 · PC2 0.1C2 · PC1 -2.4 · PC2 -0.1C3 · PC1 -0.6 · PC2 -0.7C4 · PC1 -2.3 · PC2 0.0C5 · PC1 -2.5 · PC2 -0.5C6 · PC1 -2.5 · PC2 0.2C7 · PC1 -0.6 · PC2 0.5C8 · PC1 -2.3 · PC2 -0.1C9 · PC1 -2.9 · PC2 0.2C10 · PC1 -1.9 · PC2 0.4C11 · PC1 -2.0 · PC2 0.5C12 · PC1 -1.8 · PC2 0.5T1 · PC1 1.9 · PC2 0.0T2 · PC1 1.8 · PC2 -0.1T3 · PC1 1.8 · PC2 0.5T4 · PC1 2.3 · PC2 -0.7T5 · PC1 3.0 · PC2 0.1T6 · PC1 1.6 · PC2 -1.2T7 · PC1 1.8 · PC2 0.3T8 · PC1 1.6 · PC2 -0.8T9 · PC1 1.7 · PC2 -0.0T10 · PC1 1.6 · PC2 0.2T11 · PC1 2.4 · PC2 -0.8T12 · PC1 1.5 · PC2 -0.4−202-1.0-0.50.00.51.0PC1 (41.2%)PC2 (18.9%)ConditionActive-treatedUntreatedDESeq2 VST normalization · n = 24 explants
Figure 3. Principal component analysis. Each point is one explant, placed according to its whole expression profile after normalization (VST); points close together have similar profiles. The first component (PC1, 41.2% of the variance) separates treated from untreated explants; dashed ellipses outline each group. The treatment, not a technical factor, is the main source of variation. Simulated design of 24 explants, 12 per condition.

04Differential expression

The treated versus untreated comparison uses |log2FC| > 1.5 and padj < 0.05 (Benjamini-Hochberg). In the simulated data, matrix and re-epithelialization genes are induced and inflammatory genes are reduced.

↑ COL1A1, COL3A1, FN1, TGFB1, POSTN, VEGFA, HAS2, KRT16/17 ↓ IL6, CXCL8, CCL2, MMP9
Volcano plot: active-treated vs untreatedThresholds: |log2FC| > 1.5 · padj < 0.05 (BH)COL1A1 · log2FC 2.5COL3A1 · log2FC 3.6FN1 · log2FC 1.9TGFB1 · log2FC 1.8POSTN · log2FC 1.6VEGFA · log2FC 3.1HAS2 · log2FC 3.9KRT16 · log2FC 2.5KRT17 · log2FC 3.2IL6 · log2FC -2.8CXCL8 · log2FC -2.8CCL2 · log2FC -2.8MMP9 · log2FC -4.2-5.0-2.50.02.55.001234log2 fold change (active-treated / untreated)-log10(padj)Induced by activeNot significantReduced by active
Figure 4. Differential expression. Each point is a gene. The x-axis gives the change in expression with the active (log2 fold change, right: higher, left: lower); the y-axis gives statistical confidence (higher is more significant). Dashed lines mark the thresholds |log2FC| > 1.5 and padj < 0.05. Green genes are induced by the active, blue genes are reduced, gray genes do not pass both thresholds. Simulated data.

05Expression heatmap

Clustering on a panel of 30 tissue-repair genes separates the two conditions. Collagen, growth-factor and re-epithelialization genes are higher in the treated group; IL6, CXCL8, CCL2 and MMP9 are higher in the untreated group.

Tissue-healing genes: treated vs untreated skin explantsCOL3A1KRT17FN1TGFBIACTA2TGFB1ITGB1SPP1PDGFAKRT16DPTFGF2COL1A1TIMP1HAS2ITGA5LAMC2AQP3POSTNSERPINE1KRT6AVEGFALOXMMP1MMP3CDH1IL6CXCL8MMP9CCL2ConditionUntreatedActive-treatedRelative expression10-1
Figure 5. Expression heatmap of tissue-repair genes. Rows are 30 genes involved in tissue repair, columns are explants, with the condition shown in the top band. Color gives relative expression (pink higher, blue lower). Clustering groups samples and genes with similar profiles: the two conditions separate cleanly, matrix and re-epithelialization genes are higher with the active, and inflammatory genes (IL6, CXCL8, CCL2, MMP9) are higher without it. Simulated data.

06Functional enrichment

Genes induced by the active map onto extracellular matrix organization, wound healing and keratinocyte migration. KEGG analysis converges on ECM-receptor interaction, focal adhesion and PI3K-Akt signaling. GSEA on the Hallmark gene sets places epithelial-mesenchymal transition and TGF-beta signaling at the top, with TNF-alpha/NF-kB and IL6/JAK/STAT3 signaling depleted.

GO Biological Process: ORAGenes induced by the active · clusterProfiler 4.8.1extracellular matrix organization39 geneswound healing34 genescollagen fibril organization28 geneskeratinocyte migration26 genesepithelial cell migration24 genesangiogenesis22 genescell-substrate adhesion21 genesresponse to transforming growth factor beta18 genesregulation of inflammatory response16 genesskin barrier establishment13 genes010203040Number of genes-log10(padj)196
Figure 6. GO biological processes enriched among induced genes. Each bar is a biological process; its length gives the number of induced genes it contains, and its color the statistical significance. The top processes, extracellular matrix organization, wound healing and collagen fibril organization, describe a coherent tissue-repair response. Simulated data.
KEGG pathway enrichmentGenes induced by the active · ORA · BH correctionhsa04512 ECM-receptor interactionhsa04510 Focal adhesionhsa04151 PI3K-Akt signalinghsa04010 MAPK signalinghsa04350 TGF-beta signalinghsa04370 VEGF signalinghsa04810 Regulation of actin cytoskeletonhsa04060 Cytokine-cytokine receptor interaction0.150.200.250.300.350.40Gene ratio-log10(padj)17.55.5Genes152535
Figure 7. KEGG pathways enriched among induced genes. Each point is a signaling or metabolic pathway. Its position gives the share of the pathway’s genes that are induced (gene ratio), its size the number of genes, its color the significance after Benjamini-Hochberg correction. ECM-receptor interaction, focal adhesion and PI3K-Akt signaling lead, pointing to cell-matrix contacts and repair signaling. Simulated data.
GSEA: MSigDB Hallmark gene setsActive-treated vs untreated · normalized enrichment score (NES)EPITHELIAL_MESENCHYMAL_TRANSITIONNES 2.40TGF_BETA_SIGNALINGNES 2.18ANGIOGENESISNES 2.05APICAL_JUNCTIONNES 1.85IL6_JAK_STAT3_SIGNALINGNES -1.60TNFA_SIGNALING_VIA_NFKBNES -1.75−1012Normalized enrichment score (NES)-log10(FDR)2.501.40Core genes202535clusterProfiler 4.8.1 · fgsea algorithm · BH FDR
Figure 8. GSEA on MSigDB Hallmark gene sets. Unlike the two previous analyses, GSEA uses every gene ranked by its change, not only those passing a threshold. Each point is a gene set: a positive score (right) means the set moves up with the active, a negative score (left) that it moves down; size gives the number of core genes, color the FDR. Epithelial-mesenchymal transition and TGF-beta signaling go up; TNF-alpha/NF-kB and IL6/JAK/STAT3 inflammatory signaling go down. Simulated data.

07Methods & reproducibility

Every report documents alignment (STAR 2.7.10a, two-pass, GRCh38.p14 / GENCODE v43), quantification (Salmon 1.10.0), normalization and differential expression (DESeq2 1.40.2), and functional enrichment (clusterProfiler 4.8.1, GO and KEGG over-representation, GSEA, Benjamini-Hochberg correction) with exact versions and thresholds, so that results can be audited or reproduced by your own team.

Your study

Want a report like this for your study?